New epilepsy drug aims to quiet brain storms
Symptom relief
Recruiting now
This study tests an experimental drug called NPT 2042 to see if it can reduce absence seizures in people with genetic generalized epilepsy. About 10 participants aged 16 to 75 will receive both the drug and a placebo in random order, with a two-week break in between. The main goa…
Phase: PHASE2 • Sponsor: NeuroPro Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 19:35 UTC